MRNA vs MRSN · rev $145.0M vs rev $40.5M
Moderna Inc (MRNA) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
MRNA currently screens at market cap $24.52B. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the MRNA and MRSN stock pages for the full models.
Not investment advice.